156 related articles for article (PubMed ID: 37111536)
1. Platinum(IV)-Loaded Degraded Glycol Chitosan as Efficient Platinum(IV) Drug Delivery Platform.
Lerchbammer-Kreith Y; Sommerfeld NS; Cseh K; Weng-Jiang X; Odunze U; Schätzlein AG; Uchegbu IF; Galanski MS; Jakupec MA; Keppler BK
Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111536
[TBL] [Abstract][Full Text] [Related]
2. Quaternary Ammonium Palmitoyl Glycol Chitosan (GCPQ) Loaded with Platinum-Based Anticancer Agents-A Novel Polymer Formulation for Anticancer Therapy.
Lerchbammer-Kreith Y; Hejl M; Sommerfeld NS; Weng-Jiang X; Odunze U; Mellor RD; Workman DG; Jakupec MA; Schätzlein AG; Uchegbu IF; Galanski MS; Keppler BK
Pharmaceuticals (Basel); 2023 Jul; 16(7):. PubMed ID: 37513938
[TBL] [Abstract][Full Text] [Related]
3. Combination of Drug Delivery Properties of PAMAM Dendrimers and Cytotoxicity of Platinum(IV) Complexes-A More Selective Anticancer Treatment?
Lerchbammer-Kreith Y; Hejl M; Vician P; Jakupec MA; Berger W; Galanski MS; Keppler BK
Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242758
[TBL] [Abstract][Full Text] [Related]
4. Bis- and Tetrakis(carboxylato)platinum(IV) complexes with mixed axial ligands - synthesis, characterization, and cytotoxicity.
Hoffmeister BR; Hejl M; Adib-Razavi MS; Jakupec MA; Galanski M; Keppler BK
Chem Biodivers; 2015 Apr; 12(4):559-74. PubMed ID: 25879501
[TBL] [Abstract][Full Text] [Related]
5. Tetracarboxylatoplatinum(IV) complexes featuring monodentate leaving groups - A rational approach toward exploiting the platinum(IV) prodrug strategy.
Höfer D; Varbanov HP; Legin A; Jakupec MA; Roller A; Galanski MS; Keppler BK
J Inorg Biochem; 2015 Dec; 153():259-271. PubMed ID: 26365319
[TBL] [Abstract][Full Text] [Related]
6. Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV).
Hagopian GS; Mills GB; Khokhar AR; Bast RC; Siddik ZH
Clin Cancer Res; 1999 Mar; 5(3):655-63. PubMed ID: 10100719
[TBL] [Abstract][Full Text] [Related]
7. Platinum(II) complexes of imidazophenanthroline-based polypyridine ligands as potential anticancer agents: synthesis, characterization, in vitro cytotoxicity studies and a comparative ab initio, and DFT studies with cisplatin, carboplatin, and oxaliplatin.
Alexander C; Nithyakumar A; Paul MWB; Arockia Samy N
J Biol Inorg Chem; 2018 Jul; 23(5):833-848. PubMed ID: 29934700
[TBL] [Abstract][Full Text] [Related]
8. Oxaliplatin Pt(IV) prodrugs conjugated to gadolinium-texaphyrin as potential antitumor agents.
Thiabaud G; He G; Sen S; Shelton KA; Baze WB; Segura L; Alaniz J; Munoz Macias R; Lyness G; Watts AB; Kim HM; Lee H; Cho MY; Hong KS; Finch R; Siddik ZH; Arambula JF; Sessler JL
Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7021-7029. PubMed ID: 32179677
[TBL] [Abstract][Full Text] [Related]
9. Platinum(IV) combo prodrugs containing cyclohexane-1
Gabano E; Gariboldi MB; Marras E; Barbato F; Ravera M
Dalton Trans; 2023 Aug; 52(32):11349-11360. PubMed ID: 37530512
[TBL] [Abstract][Full Text] [Related]
10. Multi-action platinum(IV) prodrugs conjugated with COX-inhibiting NSAIDs.
Liu X; Wenisch D; Dahlke P; Jordan PM; Jakupec MA; Kowol CR; Liebing P; Werz O; Keppler BK; Weigand W
Eur J Med Chem; 2023 Sep; 257():115515. PubMed ID: 37295160
[TBL] [Abstract][Full Text] [Related]
11. Mesoporous Silica Nanoparticles Enhance the Anticancer Efficacy of Platinum(IV)-Phenolate Conjugates in Breast Cancer Cell Lines.
Predarska I; Saoud M; Drača D; Morgan I; Komazec T; Eichhorn T; Mihajlović E; Dunđerović D; Mijatović S; Maksimović-Ivanić D; Hey-Hawkins E; Kaluđerović GN
Nanomaterials (Basel); 2022 Oct; 12(21):. PubMed ID: 36364539
[TBL] [Abstract][Full Text] [Related]
12. Multifunctional Pt(iv) prodrug candidates featuring the carboplatin core and deferoxamine.
Harringer S; Hejl M; Enyedy ÉA; Jakupec MA; Galanski MS; Keppler BK; Dyson PJ; Varbanov HP
Dalton Trans; 2021 Jun; 50(23):8167-8178. PubMed ID: 34031671
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cellular accumulation and cytotoxicity of cisplatin with that of tetraplatin and amminedibutyratodichloro(cyclohexylamine)platinum(IV) (JM221) in human ovarian carcinoma cell lines.
Mistry P; Kelland LR; Loh SY; Abel G; Murrer BA; Harrap KR
Cancer Res; 1992 Nov; 52(22):6188-93. PubMed ID: 1423261
[TBL] [Abstract][Full Text] [Related]
14. trans,cis,cis-bis(benzoato)dichlorido(cyclohexane-1R,2R-diamine)platinum(IV): a prodrug candidate for the treatment of oxaliplatin-refractory colorectal cancer.
Gandin V; Marzano C; Pelosi G; Ravera M; Gabano E; Osella D
ChemMedChem; 2014 Jun; 9(6):1299-305. PubMed ID: 24715720
[TBL] [Abstract][Full Text] [Related]
15. Thermogelling polymer-platinum(IV) conjugates for long-term delivery of cisplatin.
Shen W; Luan J; Cao L; Sun J; Yu L; Ding J
Biomacromolecules; 2015 Jan; 16(1):105-15. PubMed ID: 25435165
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of cyclohexane-1R,2R-diamine-based Pt(iv) dicarboxylato anticancer prodrugs: their selective activity against human colon cancer cell lines.
Gabano E; Ravera M; Perin E; Zanellato I; Rangone B; McGlinchey MJ; Osella D
Dalton Trans; 2019 Jan; 48(2):435-445. PubMed ID: 30539948
[TBL] [Abstract][Full Text] [Related]
17. Effect of chirality on the anticancer activity of Pt(II) and Pt(IV) complexes containing 1
Papadia P; Barbanente A; Ditaranto N; Hoeschele JD; Natile G; Marzano C; Gandin V; Margiotta N
Dalton Trans; 2021 Nov; 50(43):15655-15668. PubMed ID: 34673864
[TBL] [Abstract][Full Text] [Related]
18. Diamminetetrakis(carboxylato)platinum(IV) complexes--synthesis, characterization, and cytotoxicity.
Hoffmeister BR; Adib-Razavi MS; Jakupec MA; Galanski M; Keppler BK
Chem Biodivers; 2012 Sep; 9(9):1840-8. PubMed ID: 22976974
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin.
Bakalova AG; Buyukliev RT; Nikolova RP; Shivachev BL; Mihaylova RA; Konstantinov SM
Anticancer Agents Med Chem; 2019; 19(10):1243-1252. PubMed ID: 30767754
[TBL] [Abstract][Full Text] [Related]
20. Novel bis(carboxylato)dichlorido(ethane-1,2-diamine)platinum(IV) complexes with exceptionally high cytotoxicity.
Reithofer MR; Schwarzinger A; Valiahdi SM; Galanski MS; Jakupec MA; Keppler BK
J Inorg Biochem; 2008 Dec; 102(12):2072-7. PubMed ID: 18755512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
